Limbo combines real-time biodata from wearables, a mobile app, and both human and AI coaching to create individualized weight-loss and health-transformation programs. The company has been running private early access and reports members achieve an average 12% reduction in body weight within three months. Limbo says its programme nudges users into better dietary, sleep, and exercise habits and improves blood glucose and biometrics management. With the new funding, the company plans to open its service more widely in Ireland and the U.K. Leadership quotes come from co-founder and CEO Rurik Bradbury and co-founder and chairman Pat Phelan, who emphasise the service's effectiveness and global ambitions. The company is positioning itself as a tech-enabled solution to the global obesity crisis.

Total raised

$6M

Funding rounds

1

Latest round

Seed

Latest activity

Sep 2022